We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MPC:NYSEMarathon Petroleum Corporation Analysis

Data as of 2026-08-26 - not real-time

$354.88

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Marathon Petroleum Corporation is priced at $354.88 and its moving averages line up in bullish order, the shorter sitting above the longer. Across the trailing 30 sessions it gained 17.0%. Momentum indicators put RSI at 65.4 (approaching overbought) with MACD reading bullish. Watch $290.36 as support and $367.60 as the nearer resistance level.
The shares look fair, trading on 12.6 times earnings below a sector average of 20.9. The average analyst target implies 8.5% below today's level. Revenue is growing at 53.7% on a 5.5% profit margin. The 1.10% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 37.5%, a beta of -0.11 and a maximum drawdown of 18.7%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 6/10.

Top Market Events

Updated Jun 16, 2026 0 FINDLAY, Ohio, June 16, 2026 /PRNewswire/ -- Marathon Petroleum Corp.Refining margins did the heavy lifting: R&M margin more than doubled to $36.Marathon Petroleum MPC has recently been on Zacks.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 234.45
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 12.6 versus sector average of 20.9
  • Trading above the 200-day average of 234.45

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 12.6 versus sector average of 20.9
  • Analyst targets imply -8.5% versus the current price
  • Revenue growth of +53.7%

Key Metrics & Analysis

Financial Health

Revenue Growth53.70%
Profit Margin5.55%
P/E Ratio12.6
ROE42.10%
ROA8.74%
Debt/Equity133.33
P/B Ratio5.3
Op. Cash Flow$17.1B
Free Cash Flow$9.2B
Industry P/E20.9

Technical Analysis

TrendBullish
RSI65.4
Support$290.36
Resistance$367.60
MA 20$334.62
MA 50$301.38
MA 200$234.45
MACDBullish
VolumeStable
Fear & Greed Index93.36

Valuation

Fair Value$1,054.08
Target Price$324.56
Upside/Downside-8.54%
GradeFair
TypeBlend
Dividend Yield1.10%

Risk Assessment

Beta-0.11
Volatility37.51%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.